Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Description Retatrutide is an advanced triple-agonist peptide developed by Eli Lilly that simultaneously activates the GLP-1, GIP, and glucagon receptors
Krumlovsky FA, Del Greco F, Herdson PB, Lazar P
Real manufacturer with our own factory located in China 3
Webb et al
Most commercial insurance plans that cover GLP-1 for weight loss require prior authorization documenting: BMI at or above 30 (or 27 with a weight-related condition like hypertension, type 2 diabetes, dyslipidemia, or sleep apnea), and in some cases, documented prior attempts at lifestyle modification
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
.png?width=300&name=Generous%20Benefits%20Puter%20(8).png)